CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zhong Yuan Bio-Technology Holdings Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zhong Yuan Bio-Technology Holdings Ltd
Suite 901
Tesbury Centre,, 28 Queen's Road East
Phone: +852 29198916p:+852 29198916 BEVERLY HILLS, CA  00000  Hong Kong Ticker: ZHYBFZHYBF
Business Summary
Zhong Yuan Bio-Technology Holdings Ltd is an investment holding company principally engaged in the development and sale of health supplements. The Company operates its business through two segments. The Sales of Health Care Supplements segment is engaged in the development and sale of new drugs for neurological disorders, brain disease detection kits, the sale of plant-derived nervonic acid health supplements as well as others. The Company's main products are nervonic acid series supplements, marketed under the 'Muzhiyuan Neuro Enhancer' brand. The Technical Supporting Services segment is engaged in the provision of technical services

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20233/31/2023YesYes---

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
5122 Drugs, drug proprietaries, and druggists' sundries
8731 Commercial physical and biological research
5191 Farm supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Company Secretary, Director Ting TingChang 33 5/4/2017 5/4/2017
Chief Financial Officer, Director Fung MingPang 53 5/1/2020 5/1/2020
Chief Technical Officer of Bao Feng XianyangChen 39 1/1/2016 1/1/2016
4 additional Officers and Directors records available in full report.

Business Names
Business Name
Agate Island Acquisition Corporation
ZHYBF

General Information
Number of Employees: 35 (As of 6/30/2023)
Outstanding Shares: 17,709,718 (As of 3/31/2024)
Stock Exchange: OTC
Federal Tax Id: 812310905


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024